David C. Gibbons

David Gibbons brings significant industry experience to his legal practice in which he advises pharmaceutical and biotechnology companies on late-stage product development, advertising and promotion, and healthcare compliance.  Mr. Gibbons counsels on regulatory strategy related to marketing applications, including clinical development issues.  Mr. Gibbons serves as outside commercial counsel covering marketed products for pharmaceutical companies and participates as the legal reviewer on promotional review committees.  He also specializes in areas that intersect FDA and federal and state healthcare laws, advising on pharmaceutical marketing practices and transactional matters.

Prior to joining the firm in 2014, Mr. Gibbons practiced in the health care and life sciences practice of a Washington, D.C. law firm. There, he advised pharmaceutical and medical device companies regarding regulatory compliance, assisted clients undergoing government investigations, and served as regulatory counsel for private equity firms and health care companies engaged in mergers and acquisitions, joint ventures, and other strategic business affiliations.

Prior to beginning his legal career, Mr. Gibbons spent 20 years in the development of pharmaceutical and biologic products. He began his career at University of Rochester Medical Center, working on NIH-funded HIV/AIDS therapeutic and vaccine research. He later held increasingly-responsible roles within Research & Development at GlaxoSmithKline, one of the world’s largest pharmaceutical companies where his responsibilities ranged from spear-heading post-marketing responses to FDA, co-authoring regulatory submissions to FDA and EMA, leading product development teams, to developing product-specific international development and commercialization strategies for pipeline products.